The report on the global Infectious disease therapeutics market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends for the next five years. The report also tracks the emerging applications, innovative technologies, and mergers & acquisitions. It also focuses on the growth drivers and restraints for the key market players during the forecast period.
Several microorganisms such as fungi, parasites, bacteria, viruses and others cause various infectious diseases such as malaria, influenza, HIV and tuberculosis. It is the mostly occurs by inadequate personal hygiene and poor sanitation.
Such diseases are being spread either through indirect or direct contact. Anti-infective drugs are mainly used for inhibiting or destroying the market growth of diseases causing agents.
Antifungal, antiviral, antibacterial and anti-parasitic drugs are few of the anti-infective drugs.
KEY PREMIUM INDUSTRY INSIGHTS
- Private organizations and government heavily invest in the healthcare industry in order to diagnose, prevent, and treat infectious diseases; increasing investments done in the drug development for treating infectious diseases, and growing no of awareness initiatives for taken for these conditions are anticipated to fuel the global market for infectious disease therapeutics during the forecast period.
- Additionally, growing no. of patent expired and generic drugs entry in the global market for infectious disease therapeutics are projected to increase the market demand for infectious disease therapeutics owing to low prices. accessibility of diagnosis & treatment reimbursement of such infections is anticipated to boost the market growth of infectious disease therapeutics.
- However, lower penetration rate and large no. of available counterfeit drugs are anticipated to hamper the market growth of infectious disease therapeutics over the forecast period.
Regionally, the global infectious disease therapeutics market is classified into North America, Europe, Asia-Pacific, and the Rest of the World. Among these regions, North America is the leader in global infectious disease therapeutics market with maximum no.
of market share in past few years. Availability of huge no. of manufacturers, positive reimbursement scenario, and growing expenditure on healthcare are key factors that are responsible for maximum market share held in this region.
However, Asia Pacific region is likely to expand with maximum market share in the years to come.
This report analyzes the infectious disease therapeutics market by the following segments:
- Infectious Disease Therapeutics Market, by Disease Type
KEY MARKET PLAYERS
Key players in the infectious disease therapeutics market include:
- Gilead Sciences, Inc.
- GlaxoSmithKline plc
- Janssen Pharmaceutical
- F. Hoffmann-La Roche AG
- BioCryst Pharmaceuticals, Inc
- Boehringer Ingelheim GmbH
- Novartis International AG
- Merck & Co., Inc.
Category: Market Research Publishers and RetailersCompany profile: Scalar Market Research Inc. aspires to assist organizations from around the world to achieve their business goal with premium market research reports and consulting services. Our real-time industry tracking with the help of advanced analytics offers acrystal clear view of all the activities in niche markets. Our team, with thorough global understanding, works relentlessly to gather the necessary market insights, including customer analysis, competitions and global forecast. Find out more about ...
For more information: